Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.


Alan Franciscus

Editor-in-Chief

HCV Advocate


Thursday, April 23, 2015

EASL 2015: Hepatitis C Infection Linked to Increased Risk of Heart Disease

Results from a new study demonstrate that chronic hepatitis C virus (HCV) infection is associated with a higher risk of developing cardiovascular diseases and significantly increases cost of care and length of time in hospital. Based on these results, revealed today at The International Liver Congress 2015, study investigators conclude that chronic HCV infection should be considered a risk factor for the development of cardiovascular diseases.

In the study, inpatient prevalence of diagnosed HCV infection was 1.9%. For these patients, the adjusted odds ratio (OR) for acute myocardial infarction was 2.29 (CI: 2.22?2.36); for coronary artery disease: 1.88 (CI: 1.83?1.93); for cerebrovascular accident: 1.98 (CI: 1.93?2.04) and for congestive heart failure: 1.08 (CI: 1.06-1.10).

In this study, patients with HCV infections were characterized using the weighted 2011 Nationwide Inpatient Sample (NIS) data.

Read more...


Posted by at
Labels: , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)